MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to fulgent
-$24,826K
(-115.32%↓ Y/Y)
Net loss
attributable to...
-$448K
(-21.41%↓ Y/Y)
Net loss from
consolidated operations
-$25,274K
(-112.40%↓ Y/Y)
(benefit from) provision
for income taxes
-$704K
(-500.00%↓ Y/Y)
Interest income
$8,651K
(7.89%↑ Y/Y)
Clinical Institutional
Contracts
$40,933K
(-0.95%↓ Y/Y)
Clinical Insurance
Contracts
$27,379K
(-10.95%↓ Y/Y)
Clinical Patient
Contracts
$2,826K
(102.58%↑ Y/Y)
Other income
(expense), net
$10K
(-85.29%↓ Y/Y)
Loss before income
taxes
-$25,978K
(-121.60%↓ Y/Y)
Total other income,
net
$8,644K
(7.09%↑ Y/Y)
Revenue
$71,138K
(-3.16%↓ Y/Y)
Interest expense
$17K
(21.43%↑ Y/Y)
Operating loss
-$34,622K
(-74.90%↓ Y/Y)
Gross profit
$21,490K
(-24.19%↓ Y/Y)
Cost of revenue
$49,648K
(10.04%↑ Y/Y)
Total operating
expenses
$56,112K
(16.56%↑ Y/Y)
General and
administrative
$27,684K
(9.46%↑ Y/Y)
Research and development
$14,176K
(14.37%↑ Y/Y)
Selling and marketing
$12,221K
(44.37%↑ Y/Y)
Amortization of intangible
assets
$2,031K
(2.06%↑ Y/Y)
Back
Back
Income Statement
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)
source: myfinsight.com